{"id":"W4386282286","doi":"10.1016/s2152-2650(23)00763-2","title":"POSTER: IBCL-489 Mosunetuzumab Retreatment Is Effective and Well-Tolerated in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"Universitat de Barcelona; Rigshospitalet; Universitair Medisch Centrum Groningen; Universiteit Leiden; Leids Universitair Medisch Centrum; University of California, Los Angeles; Memorial Sloan-Kettering Cancer Center; Karolinska Institutet; Gentofte Hospital; Rijksuniversiteit Groningen; Odense Universitetshospital; Helsingin Yliopisto","keywords":"Refractory (planetary science); Medicine; Lymphoma; Oncology; Internal medicine; Hodgkin lymphoma; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002134689,0.000312012,0.0005503091,0.0001386195,0.0002973804,0.0002952796,0.0002164617,0.0004045488,0.007679728],"category_scores_gemma":[0.0002538767,0.00008534423,0.0002990011,0.0000863266,0.0001372092,0.0002056867,0.0001086964,0.001083634,0.001515408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002441627,"about_ca_system_score_gemma":0.0001936237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005820068,"about_ca_topic_score_gemma":0.001429756,"domain_scores_codex":[0.999933,0.00001464297,0.000005057962,0.000008148611,0.00001129352,0.00002790805],"domain_scores_gemma":[0.9999207,0.00001399217,0.00001104926,0.000003900365,0.00000740016,0.00004292983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06273373,0.004908683,0.01003945,0.0008273147,0.0005562413,0.003237697,0.0002070981,0.0008995821,0.09846433,0.0003700242,0.06932668,0.7484292],"study_design_scores_gemma":[0.06862042,0.1443782,0.4096303,0.0005431967,0.002014655,0.01472317,0.0003929316,0.006157765,0.07309703,0.001036764,0.2792468,0.0001586751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9405507,0.02039779,0.0009270589,0.006425455,0.002059503,0.0003902476,0.001039552,0.0004979817,0.02771168],"genre_scores_gemma":[0.9780948,0.003381865,0.0005239931,0.002326204,0.000851195,0.00008000245,0.0007982621,0.00003852904,0.01390523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007679728,"threshold_uncertainty_score":0.02569127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01263369242143094,"score_gpt":0.2837801952237903,"score_spread":0.2711465028023594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}